Acceleration: minimizing time to market

It’s well known that in drug development, time to market is much longer than most other markets. The business models, the pitch to investors and exit strategies need to reflect this reality. These are the keystones in our acceleration programme. 

The unlock_ team is experienced in helping scaling companies find the funding they need to grow rapidly.

Did you know? We are host to a whopping 515 Medical Specialists